Previous Page  10 / 16 Next Page
Information
Show Menu
Previous Page 10 / 16 Next Page
Page Background

Page 21

Notes:

Journal of Neurology and Clinical Neuroscience | Volume: 03

8

th

International Conference on

NEUROLOGICAL DISORDERS,

CENTRAL NERVOUS SYSTEM AND STROKE

&

International Conference on

NEUROLOGY AND NEUROSURGERY

December 04-05, Dubai, UAE

Joint event on

J Neurol Clin Neurosci, Volume: 03

To study serummagnesium level in patient withMigraine and efficacy of combination

of folic acid and magnesium in treatment of Migraine

Shalin Shah

Artemis Institute, India

Background

: Pathophysiology of migraine involves

different mechanisms including modulation of central

and peripheral pain structures and release of vasoactive

peptides. Studies revealed decreased levels of

micronutrients riboflavin, magnesium and coenzyme.

Deficit of nutrients could play role in the pathophysiology.

Treatment with nutritional supplement might benefit for

patients who cannot tolerate chemical drugs.

Methods

: In this cross sectional analytical observational

study, Magnesium levels of 56 patient checked. Then

recruited into Folic acid + magnesium (FA+Mg) and

Flunarizine. Headache Impact Test (HIT) scorewas evaluated

pre and post treatment after 2 month. Concomitant

improvement and adverse events was checked.

Results

: Mean magnesium was 1.9877 ± 0.1355 with

range between 1.65-2.34mg. 21.4 % had low magnesium.

Mean magnesium found in lower normal range.Pre HIT

was between 56-66 with mean of 66.30. In FA+MG , 27

patients had Pre HIT of 64.93 ± 5.196 and in flunarizine , 29

patients had 67.59 ± 4.524.Comparison showed significant

difference (p value - 0.046).Post HIT in FA+MG was 53.81

± 10.340 and Flunarizine was 54.55 ± 8.919. Comparison

showed no statistical difference (p value - 0.776).

Comparing percentage difference with FA+MG having

17.0898 ± 14.79 and flunarizine having 18.7929 ± 15.3326

with no statistical differences ( p value - 0.674). Response

to treatment and Side effects showed no statistical

difference between both groups (p value - 0.685).

Conclusion

: Hypomagnesemia would be one factor

causing migraine and should be checked in patients with

suspected migraine.Starting prophylaxis with Combination

of Folic acid and magnesium would be better.

Biography

Shalin Shah, has finished his DM neurology last year from prestigious

amrita institute of medical science , kochi, India. His mentor was Dr.

Anand kumar who is head of department in amrita institute. He had

done work and thesis of vascular headache. At present he is doing his

Stroke and neurointervention fellowship.

e:

shalin9081@gmail.com